Filing Details

Accession Number:
0001104659-20-070840
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-08 16:08:59
Reporting Period:
2020-06-05
Accepted Time:
2020-06-08 16:08:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1279704 Cellectar Biosciences Inc. CLRB Pharmaceutical Preparations (2834) 043321804
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1326487 Dov Elefant C/O Cellectar Biosciences, Inc.
100 Campus Drive
Florham NJ 07932
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-06-05 4,348 $1.15 4,348 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series H Warrants Acquisiton 2020-06-05 2,174 $0.01 2,174 $1.21
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,174 2020-06-05 2025-06-05 No 4 P Direct